Post by
Eoganacht on Feb 17, 2022 5:06pm
Commercialization Timeline Change
In the Sep 2021 Corporate Presentation, on the Phase II Timeline page, commercialization is set to begin in mid-2025 and there is a note - Partner with Big Pharma To Commercialize.
In the Feb 7 2022 Corporate Presentation, on the Phase II Timeline page, commercialization is set to begin in January 2023 (11 months from now) and there is no mention of partnering with big pharma.
What has changed in the last 5 months?
Comment by
enriquesuave on Feb 17, 2022 5:09pm
No partnership,so maybe a Buyout instead? Who knows, or just an oversight?
Comment by
gebremeskel on Feb 17, 2022 5:19pm
Maybe leaving out mention of a partnership was an oversight, but how could we be granted accelerated approval by January 2023? Could there have been a communication from the FDA we haven't heard about yet?
Comment by
CancerSlayer on Feb 17, 2022 7:22pm
Or, & more likely....the "commercialization phase" timeline (starting early 2023) may simply represent business planning/strategizing for a future commercial roll-out (I.e. feasibility, costs, price point, etc.) prior to actual market approval (projected to be mid-end of 2025).
Comment by
O12009 on Feb 17, 2022 8:31pm
In the past when we find out new information we always go back to prior news releases and there it is spelled out. So I don't think it's a mistake when they say January 2023 and they leave out that's with a partner. This should make for a fantastic news release.
Comment by
CancerSlayer on Feb 17, 2022 9:58pm
I wouldn't mind catching that Big Fish in the upstream as long as it spawns plenty of commercial & shareholder success in the downstream. Expecting good news, but I'll take fantastic. Good luck.
Comment by
99942Apophis on Feb 17, 2022 10:14pm
Hey guys this coming Monday February 21 puts us into the beginning time frame where the Newsletter "might" be released! Please keep in mind the time frame extends through to the week of March 7 and the Friday of that week being March 11. Are we there? Yes we are almost there!
Comment by
Legit62 on Feb 18, 2022 8:47am
would tend to agree we are really close, would be nice monday but march is almost here, also if they state commercialization early 2023 i think would ease the minds and we head up fast
Comment by
floatinketucky on Feb 17, 2022 5:24pm
So a 3 year step forward of commercializion timline... Now do ya'll recall that lil ol pr about the little fda darling being on the phone to daddy FDA. FDA was like little darling you just call me right up if you want to talk... Looks like they been chattin it up.
Comment by
floatinketucky on Feb 17, 2022 5:28pm
And whats changed is the stataus ot the data with each reporting. They prolly gonna chat some more with big daddy FDA... mmmm hhhh mmmmmm Might be the geentle thing to do.. Somewhere is the data forward from Nov 29 .. migntheybe eyes on it now???
Comment by
floatinketucky on Feb 17, 2022 6:11pm
As a Fast Track designee, Theralase® will have access to early and frequent communications with the FDA to discuss Theralase’s development plans and ensure timely collection of the appropriate clinical data to support the approval process.
Comment by
skys1 on Feb 18, 2022 2:00pm
What has changed in the last 5 months? Dr. Vera. That was pre Dr Vera. Post 10/21 or post Dr Vera's arrival, Company opinions and forward guidance will substantially influenced by Dr Vera's vast experience.
Comment by
fredgoodwinson on Feb 18, 2022 2:21pm
Yes skys1 - Vera`s appointment was transformational for the Company and her willingness to join a huge endorsement of Theralases`s tech.
Comment by
skys1 on Feb 18, 2022 2:55pm
Agree Fred, Now with Dr Vera at the trial helm, TLT is a very different company, and I might add, a substantially better company that knows where it is going, and how to get there.